ImmunityBio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ImmunityBio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • ImmunityBio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$80.3M, a 0.15% decline year-over-year.
  • ImmunityBio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$360M, a 0.44% increase year-over-year.
  • ImmunityBio, Inc. annual Operating Income (Loss) for 2023 was -$362M, a 3.12% decline from 2022.
  • ImmunityBio, Inc. annual Operating Income (Loss) for 2022 was -$351M, a 6.36% decline from 2021.
  • ImmunityBio, Inc. annual Operating Income (Loss) for 2021 was -$330M, a 49.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$360M -$80.3M -$117K -0.15% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$360M -$99.3M -$14.2M -16.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$346M -$95.2M +$16.4M +14.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$362M -$85.4M -$489K -0.58% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$362M -$80.1M +$10.7M +11.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$372M -$85.1M -$5.52M -6.94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$367M -$112M -$15.6M -16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$351M -$84.9M -$5.63M -7.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$346M -$90.8M -$12M -15.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$334M -$79.6M +$6.28M +7.32% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$340M -$96M -$9.71M -11.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$330M -$79.3M -$48.4M -157% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 -$282M -$78.8M -$13M -19.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$269M -$85.9M -$35M -68.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$234M -$86.3M -$49.6M -135% Jan 1, 2021 Mar 31, 2021 10-K 2024-03-19
Q4 2020 -$184M -$30.9M -$14.8M -91.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-04
Q3 2020 -$170M -$65.9M -$49.8M -310% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$120M -$50.9M -$33.6M -194% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$86.2M -$36.7M -$18.4M -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$67.8M -$16.1M +$1.61M +9.08% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$69.4M -$16.1M +$8.04M +33.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-04
Q2 2019 -$77.5M -$17.3M +$11M +38.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-04
Q1 2019 -$88.4M -$18.3M +$9.95M +35.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-04
Q4 2018 -$98.4M -$17.7M +$7.68M +30.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$106M -$24.1M +$334K +1.37% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-25
Q2 2018 -$106M -$28.3M -$4.46M -18.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-25
Q1 2018 -$102M -$28.3M -$2.82M -11.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-25
Q4 2017 -$99.1M -$25.4M -$251K -1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$98.9M -$24.4M +$8.33M +25.4% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-13
Q2 2017 -$107M -$23.8M +$11.1M +31.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-13
Q1 2017 -$118M -$25.5M +$6.15M +19.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-13
Q4 2016 -$124M -$25.1M +$4.78M +16% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$129M -$32.8M +$13.7M +29.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$143M -$35M +$95.4M +73.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$238M -$31.6M +$485K +1.51% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$239M -$29.9M -$27.3M -1037% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$212M -$46.5M -$45.5M -4955% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$166M -$130M -$129M -10784% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 -$36.9M -$32.1M -$31.3M -3786% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$5.58M -$2.63M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$919K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$1.2M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$826K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.